Overview
- Comprehensively addresses the health concerns of 1.65 billion children under the age of 14 living in poorly resourced settings; their need for safe and effective evidence-based treatment from conception to adolescence is highlighted
- Provides a unique perspective on therapeutic decision-making, pediatric pharmacology and pharmacy through a development lens
- Emphasizes the importance of access to treatment validated for children at every age and stage of development…an issue that goes well beyond affordability
Access this book
Tax calculation will be finalised at checkout
Other ways to access
Table of contents (30 chapters)
-
Front Matter
-
Introduction and Context
-
Front Matter
-
-
Factors Enabling Improved Therapy
-
Front Matter
-
Keywords
About this book
This book is intended to communicate current best practice in pediatric clinical pharmacology and clinical pharmacy with special consideration of the prevailing circumstances and most pressing needs in developing countries. It also addresses measures that may be taken in countries with emerging economies through organizational and political adjustments to reduce unacceptable levels of morbidity and mortality among children and pregnant women with treatable diseases.
Editors and Affiliations
About the editors
Since 2003, Dr Stuart MacLeod has been Professor of Pediatrics at the University of British Columbia in Vancouver, Canada. He was also Director of the Child & Family Research Institute at BC Children’s Hospital until January 2010 and remains a senior clinician scientist at the Institute.
Dr MacLeod received an MD from the University of Toronto in 1967 and completed postgraduate training in clinical pharmacology in 1973 at McGill University where he obtained a PhD in pharmacology in 1972. In the early stages of his career his research interests focused on biochemical pharmacology, drug hepatotoxicity and drug biotransformation. In 1979 Dr MacLeod became the founding leader of a Division of Pediatric Clinical Pharmacology at Toronto’s Hospital for Sick Children. This University of Toronto unit has now thrived for 35 years and is the world’s leading centre for training and research in pediatric pharmacology and toxicology.
Dr MacLeod served as Dean of the Faculty of Health Sciences at McMaster University (1987-1992) and following the deanship founded the Centre for Evaluation of Medicines with a focus on therapeutics teaching, clinical pharmacology, population health sciences and pharmacoepidemiology.
Since 1986, Dr MacLeod has held a major interest in international health with a focus on African maternal-child health. His current scientific interests embrace the multitude of factors that influence safe and effective drug treatments for children and the use of research findings to inform clinical and public policy.
Bibliographic Information
Book Title: Optimizing Treatment for Children in the Developing World
Editors: Stuart MacLeod, Suzanne Hill, Gideon Koren, Anders Rane
DOI: https://doi.org/10.1007/978-3-319-15750-4
Publisher: Adis Cham
eBook Packages: Medicine, Medicine (R0)
Copyright Information: Springer International Publishing Switzerland 2015
Hardcover ISBN: 978-3-319-15749-8Published: 29 May 2015
Softcover ISBN: 978-3-319-38058-2Published: 17 October 2016
eBook ISBN: 978-3-319-15750-4Published: 12 May 2015
Edition Number: 1
Number of Pages: XVII, 332
Number of Illustrations: 8 b/w illustrations, 13 illustrations in colour
Topics: Pediatrics, General Practice / Family Medicine, Pharmacotherapy
Industry Sectors: Biotechnology, Health & Hospitals, Pharma